Contact Center Solutions Industry News

TMCNet:  Research and Markets: Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2012

[November 12, 2012]

Research and Markets: Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2012

Nov 12, 2012 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/ddvnvx/global_attention) has announced the addition of the "Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Attention Deficit Hyperactivity Disorder patient population study in a new report Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Attention Deficit Hyperactivity Disorder epidemiology, Attention Deficit Hyperactivity Disorder diagnosed patients, and Attention Deficit Hyperactivity Disorder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Attention Deficit Hyperactivity Disorder derived from epidemiological analysis, percentage of patients diagnosed with Attention Deficit Hyperactivity Disorder, and percentage of patients treated with Attention Deficit Hyperactivity Disorder therapy.

The study helps executives estimate Attention Deficit Hyperactivity Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Attention Deficit Hyperactivity Disorder prevalence, Attention Deficit Hyperactivity Disorder diagnosis rate, and Attention Deficit Hyperactivity Disorder treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report: - Attention Deficit Hyperactivity Disorder: Disease Definition - Attention Deficit Hyperactivity Disorder Patient Flow - Attention Deficit Hyperactivity Disorder Prevalence - Attention Deficit Hyperactivity Disorder Diagnosed Patients - Attention Deficit Hyperactivity Disorder Treated Patients For more information visit http://www.researchandmarkets.com/research/ddvnvx/global_attention CONTACT: Research and Markets, Laura Wood, Senior Manager.

press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals (http://www.researchandmarkets.com/categories.asp cat_id=16&campaign_id=ddvnvx) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

[ Back To Contact Center Solutions's Homepage ]

Subscribe here for your FREE Contact
Center Solutions
enewslettter.

Events

Weekly Live Demo
Contact Center Solutions

Register Today!


Weekly Live Demo
CaaS Small Center

Register Today!